Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxalate production" refers to the **metabolic process** by which the body synthesizes **oxalic acid (oxalate)**, primarily in the liver. The terminal steps involve conversion of glyoxylate to oxalate, catalyzed mainly by lactate dehydrogenase (LDH) rather than glycolate oxidase under physiological conditions. This process is modulated by factors such as NADH, lactate, alanine, and the overall metabolic state of hepatocytes. While not itself a molecular target like an enzyme or receptor, dysregulation of this pathway contributes to pathological conditions such as kidney stone formation and primary hyperoxaluria[1]. Thus, therapeutic strategies often focus on inhibiting enzymes involved in this pathway rather than targeting "oxalate production" per se.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxalate production.